A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but ...

A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...

Congruence secures a $5 million grant to advance innovative therapies for GBA1 Parkinson's disease, enhancing hope for ...

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

The side effects that come with many cancer treatments can cause people to delay or avoid treatment.